Lithium Carbonate description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Lithium Carbonate

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

DOSAGE AND ADMINISTRATION

LITHIUM CARBONATE DESCRIPTION





CLINICAL PHARMACOLOGY



INDICATIONS & USAGE




WARNINGS






DOSAGE AND ADMINISTRATION



Usage in Pregnancy



Usage in Nursing Mothers


Pediatric Use



PRECAUTIONS

DOSAGE AND ADMINISTRATION


WARNINGS







Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)



PREGNANCY

Pregnancy Category D
WARNINGSUsage in Pregnancy

NURSING MOTHERS

WARNINGSUsage in Nursing Mothers

PEDIATRIC USE

WARNINGSPediatric Use

GERIATRIC USE




LITHIUM CARBONATE ADVERSE REACTIONS







Central Nervous System


Cardiovascular


Gastrointestinal


Genitourinary


Dermatologic


Autonomic Nervous System


Thyroid Abnormalities
PRECAUTIONS

EEG Changes


EKG Changes


Miscellaneous




OVERDOSAGE

ADVERSE REACTIONS

Treatment




DOSAGE & ADMINISTRATION

Acute Mania


*

Long-Term Control


*

Important Considerations
  • ●Blood samples for serum lithium determinations should be drawn immediately prior to the next dose when lithium concentrations are relatively stable (i.e., 8 to 12 hours after previous dose). Total reliance must not be placed on serum concentrations alone. Accurate patient evaluation requires both clinical and laboratory analysis.
  • ●Lithium Carbonate Extended Release Tablets USP must be swallowed whole and never chewed or crushed.

HOW SUPPLIED











PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Lithium Carbonate



Lithium Carbonate







Lithium Carbonate

Lithium Carbonate TABLET, EXTENDED RELEASE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-156(NDC:0054-0021-25)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
LITHIUM CARBONATE LITHIUM CATION 300 mg

Inactive Ingredients

Ingredient Name Strength
CALCIUM STEARATE
povidone
SODIUM CHLORIDE
SODIUM LAURYL SULFATE
sorbitol

Product Characteristics

Color Size Imprint Code Shape
brown 10 mm 54;107 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-156-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076832 2011-04-13


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.